

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | G protein-coupled receptors are seven-transmembrane proteins that can be activated by free fatty acid. GW950 is a small-molecule agonist of GPR40 and GPR120 with pEC50 values of 7.32±0.03 and 5.46±0.09, respectively. It also induced intracellular Ca2+ mobilization in HEK293 cells expressing GPR40 (pEC50=7.32±0.03) or GPR120 (pEC50=5.46±0.09). In MIN6 mouse insulinoma cell line, GW9508 induced a concentration-dependent increase in high glucose (25mM)-stimulated insulin secretion with a pEC50 of 6.14±0.03[3]. The administration of 200mM GW9508 to the ear 1h before each DNFB treatment significantly attenuated ear swelling in BALB/c mice compared with the controls. GW9508 treatment also significantly reduced the expression of CCL5 and eosinophils infiltrating in the skin compared to the vehicle-treated group. In C57BL/6 mice subjected to DNFB-induced CHS, application of GW9508 at 10-100μM suppressed ear swelling in a dose-dependent manner[4]. |
| Concentration | Treated Time | Description | References | |
| 661W cells | 14 µM | 8 h | To study the effect of GW9508 on Hif1a protein expression | Nat Med. 2016 Apr;22(4):439-45. |
| 661W cells | 14 µM | 12 h | To study the effect of GW9508 on Vegfa secretion | Nat Med. 2016 Apr;22(4):439-45. |
| CLU189 cells | 100 μM | 1 h | To evaluate the effect of GW9508 on IKK activity in CLU189 cells, results showed a trend but no significant reduction in IKK activity. | J Neuroinflammation. 2017 Apr 26;14(1):91. |
| BV2 cells | 100 μM | 1 h | To evaluate the effect of GW9508 on IKK activity in BV2 cells, results showed a significant trend in reducing IKK activity. | J Neuroinflammation. 2017 Apr 26;14(1):91. |
| Human neutrophils | 1 and 10 μM | 10 min | GW9508 increased neutrophil chemotaxis in response to IL-8 and enhanced neutrophil phagocytosis of E. coli. | coli Infections. Front Immunol. |
| hippocampal CA1 pyramidal neurons | 20 µM | GW9508 reduced NMDAR-mediated postsynaptic currents, indicating that GPR40 modulates NMDAR-mediated synaptic transmission. | Sci Adv. 2018 Oct 17;4(10):eaau2357. | |
| BRIN-BD11 cells | 20 μM | 60 min | GW9508 increased superoxide and H2O2 content at 5.6 mM and 8.3 mM glucose concentrations, but not at 16.7 mM glucose concentration. | Redox Rep. 2020 Dec;25(1):41-50. |
| roGFP2-Orp1 BRIN-BD11 cells | 20 μM | 60 min | GW9508 increased H2O2 content at 5.6 mM and 8.3 mM glucose concentrations, but not at 16.7 mM glucose concentration. | Redox Rep. 2020 Dec;25(1):41-50. |
| brown preadipocytes | 100 μM | 24 h | GW9508 treatment significantly induced the expression of UCP1, Glut1, and FGF21, and strongly increased the secretion of FGF21 protein. | Nat Commun. 2016 Nov 17;7:13479. |
| brown adipocytes | 100 μM | 24 h | GW9508 treatment significantly increased the thermogenic activity of brown adipocytes and promoted the release of FGF21. | Nat Commun. 2016 Nov 17;7:13479. |
| beige preadipocytes | 100 μM | 24 h | GW9508 treatment significantly induced the differentiation of beige adipocytes and promoted the release of FGF21. | Nat Commun. 2016 Nov 17;7:13479. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Vldlr−/− mice | Intraperitoneal | 14 µM | Once daily for 7 days | To study the effect of GW9508 on retinal glucose uptake and RAP-like lesions | Nat Med. 2016 Apr;22(4):439-45. |
| Swiss mice | High-fat diet-induced obesity model | Intracerebroventricular injection | 1.0 mM | Twice daily for 6 days | To evaluate the effect of GW9508 on energy efficiency and inflammatory gene expression in obese mice, results showed that GW9508 reduced energy efficiency and decreased the expression of inflammatory genes. | J Neuroinflammation. 2017 Apr 26;14(1):91. |
| Mice | E. coli infection model | Intraperitoneal injection | 10 mg/kg | Once, lasting 12 hours | GW9508 increased peritoneal leukocyte infiltration, enhanced phagocytic capacity, and modulated lipid mediator production. | coli Infections. Front Immunol. |
| Mice | KA-induced temporal lobe epilepsy model | Intracerebroventricular injection | 1 µg/mouse | Daily for seven consecutive days | GW9508 decreased the number of seizure-like events and the total time spent in SLEs, indicating its antiepileptic effect. | Sci Adv. 2018 Oct 17;4(10):eaau2357. |
| Rats | Germinal matrix hemorrhage (GMH) model | Intranasal administration | 0.84 mg/kg, 2.5 mg/kg, 7.5 mg/kg | Administration at 1 h, 25 h, and 49 h after GMH induction | GW9508 attenuated neuroinflammation and improved neurological function via the PAK4/CREB/KDM6B pathway after GMH | J Neuroinflammation. 2021 Jul 18;18(1):160 |
| Mice | C57BL6 mice | Diet | 50 mg/kg | Once daily for 7 days | GW9508 treatment significantly upregulated thermogenic genes in BAT and induced browning in iWAT, while increasing blood FGF21 levels. | Nat Commun. 2016 Nov 17;7:13479. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.88mL 0.58mL 0.29mL |
14.39mL 2.88mL 1.44mL |
28.78mL 5.76mL 2.88mL |
|
| CAS号 | 885101-89-3 |
| 分子式 | C22H21NO3 |
| 分子量 | 347.41 |
| SMILES Code | OC(=O)CCC1=CC=C(NCC2=CC(OC3=CC=CC=C3)=CC=C2)C=C1 |
| MDL No. | MFCD09753282 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | DGENZVKCTGIDRZ-UHFFFAOYSA-N |
| Pubchem ID | 11595431 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(302.24 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1